Abstract
Squamous epithelial dysplasia is often observed multifocally in the cancerous oesophagus and is presumably considered to be a pre-cancerous lesion. A mutation of the p53 tumour suppressor gene is commonly identified in oesophageal cancer and dysplasia. p53 mutations can be anticipated immunohistochemically. In order to confirm the biological and clinical significance of p53 expressions in oesophageal field carcinogenesis, immunostaining for p53 in cancerous and multifocal precancerous lesions from resected human oesophagus was systematically investigated, while paying special attention to the contiguity of these lesions. Lesions expressing p53 were detected in 46.5% (20 of 43 lesions) of the invasive carcinoma, and in 51.0% (46 of 90 lesions) of the carcinoma in situ, and in 51.4% (92 of 179 lesions) of the dysplasia. Next, the p53 expression in dysplasia was compared with that in carcinoma for the same case. 37 of 39 (94.8%) dysplasias contiguous to p53-positive carcinomas also expressed p53 (P < 0.0001). On the other hand, the isolated dysplasias without contiguity to p53-positive carcinomas, only expressed p53 protein in 44.0% (11 of 25 lesions). No significant correlations were found between the p53 staining and either the clinicopathological features or prognosis. Discordant p53 alterations, such as those seen in cancerous and isolated precancerous lesions, may thus demonstrate further evidence for a multicentric or field carcinogenesis of the human oesophagus. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Bennett WP, Hollstein MC, He A, Zhu SM, Resau J, Trump BF, Metcalf RA, Welsh JA, Midgley C, Lane DP and Harris CC (1991) Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer. Oncogene 6: 1779–1784
Bennett WP, Hollstein MC, Metcalf RA, Welsh JA, He A, Zhu SM, Kusters I, Resau JH, Trump BF, Lane DP and Harris CC (1992) p53 mutation and protein accumulation during multistage human esophageal carcinogenesis. Cancer Res 52: 6092–6097
Ciechanover A, DiGiuseppe JA, Bercovich B, Orian A, Richter JD, Schwartz AL and Brodeur GM (1991) Degradation of nuclear oncoproteins by the ubiquitin system in vitro. Proc Natl Acad Sci USA 88: 139–143
Finlay CA, Hinds PW, Tan TH, Eliyahu D, Oren M and Levine AJ (1988) Activating mutations for transformation by p53 produce a gene product that forms an hsc70–p53 complex with an altered half-life. Mol Cell Biol 8: 531–539
Gao H, Wang LD, Zhou Q, Hong JY, Huang TY and Yang CS (1994) p53 tumour suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China. Cancer Res 54: 4342–4346
Hall PA and Lane DP (1994) p53 in tumour pathology: can we trust immunohistochemistry? revisited. J Pathol 172: 1–4
Hollstein M, Sidransky D, Vogelstein B and Harris CC (1991) p53 mutations in human cancers. Science 253: 49–53
Ikeda G, Isaji S, Chandra B, Watanabe M and Kawarada Y (1999) Prognostic significance of biologic factors in squamous cell carcinoma of the esophagus. Cancer 86: 1396–1405
Kanamoto A, Kato H, Tachimori Y, Watanabe H, Nakanishi Y, Kondo H, Yamaguchi H, Gotoda T, Muro K and Matsumura Y (1999) No prognostic significance of p53 expression in esophageal squamous cell carcinoma. J Surg Oncol 72: 94–98
Kawabara S, Ajioka Y, Watanabe H, Hitomi J, Nishikura K and Hatakeyama K (1998) Heterogeneity of p53 mutational status in esophageal squamous cell carcinoma. Jpn J Cancer Res 89: 405–410
Kobayashi S, Koide Y, Endo M, Isono K and Ochiai T (1999) The p53 gene mutation is of prognostic value in esophageal squamous cell carcinoma patients in unified stages of curability. Am J Surg 177: 497–502
Koga Y, Sugimachi K, Kuwano H, Mori M and Matsufuji H (1988) Cytophotometric DNA analysis of esophageal dysplasia and carcinoma induced in rats by N-methyl-N-amylnitrosamine. Eur J Cancer Clin Oncol 24: 643–651
Koga Y, Kuwano H and Sugimachi K (1996) Biologic characteristics of esophageal epithelial dysplasia assessed by proliferating cell nuclear antigen. Cancer 77: 237–244
Kuwano H, Matsuda H, Matsuoka H, Kai H, Okudaira Y and Sugimachi K (1987) Intra-epithelial carcinoma concomitant with esophageal squamous cell carcinoma. Cancer 59: 783–787
Kuwano H, Nagamatsu M, Ohno S, Matsuda H, Mori M and Sugimachi K (1988) Coexistence of intraepithelial carcinoma and glandular differentiation in esophageal squamous cell carcinoma. Cancer 62: 1568–1572
Kuwano H, Watanabe M, Sadanaga N, Ikebe M, Mori M and Sugimachi K (1993) Squamous epithelial dysplasia associated with squamous cell carcinoma of the esophagus. Cancer Lett 72: 141–147
Lam KY, Tsao SW, Zhang D, Law S, He D, Ma L and Wong J (1997) Prevalence and predictive value of p53 mutation in patients with oesophageal squamous cell carcinomas: a prospective clinico-pathological study and survival analysis of 70 patients. Int J Cancer 74: 212–219
Mori M, Adachi Y, Matsushima T, Matsuda H, Kuwano H and Sugimachi K (1993) Lugol staining pattern and histology of esophageal lesions. Am J Gastroenterol 88: 701–705
Morita M, Kuwano H, Yasuda M, Watanabe M, Ohno S, Saito T, Furusawa M and Sugimachi K (1994) The multicentric occurrence of squamous epithelial dysplasia and squamous cell carcinoma in the esophagus. Cancer 74: 2889–2895
Nagamatsu M, Mori M, Kuwano H, Sugimachi K and Akiyoshi T (1992) Serial histologic investigation of squamous epithelial dysplasia associated with carcinoma of the esophagus. Cancer 69: 1094–1098
Rogel A, Popliker M, Webb CG and Oren M (1985) p53 cellular tumour antigen: Analysis of mRNA levels in normal adult tissues, embryos and tumours. Mol Cell Biol 5: 2851–2855
Sarbia M, Porschen R, Borchard F, Horstmann O, Willers R and Gabbert HE (1994) p53 protein expression and prognosis in squamous cell carcinoma of the esophagus. Cancer 74: 2218–2223
Shi ST, Yang GY, Wang LD, Xue Z, Feng B, Ding W, Xing EP and Yang CS (1999) Role of p53 gene mutations in human esophageal carcinogenesis: results from immunohistochemical and mutation analyses of carcinomas and nearby noncancerous lesions. Carcinogenesis 20: 591–597
Shimada Y, Imamura M, Watanabe G, Uchida S, Harada H, Makino T and Kano M (1999) Prognostic factors of oesophageal squamous cell carcinoma from the perspective of molecular biology. Br J Cancer 80: 1281–1288
Sobin LH and Wittekind CH (1997). TNM Classification of Malignant Tumours, 5th edn, Wiley-Liss: New York
Tsutsui S, Kuwano H, Yasuda M, Nozoe T, Watanabe M, Kitamura M and Sugimachi K (1995) Extensive spreading carcinoma of the esophagus with invasion restricted to the submucosa. Am J Gastroenterol 90: 308–313
van den Heuvel SJL, van Laar T, Kast WM, Melief CJM, Zantema A and van der Eb AJ (1990) Association between the cellular p53 and the adenovirus 5 E1B-55kd proteins reduces the oncogenicity of Ad-transformed cells. EMBO J 8: 2621–2629
Vijeyasingam R, Darnton SJ, Jenner K, Allen CA, Billingham C and Matthews HR (1994) Expression of p53 protein in oesophageal carcinoma: clinicopathological correlation and prognostic significance. Br J Surg 81: 1623–1626
Wagata T, Shibagaki I, Imamura M, Shimada Y, Toguchida J, Yandell DW, Ikenaga M, Tobe T and Ishizaki K (1993) Loss of 17p, mutation of p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas. Cancer Res 53: 846–850
Wang LD, Hong JY, Qiu SL, Gao H and Yang CS (1993) Accumulation of p53 protein in human esophageal precancerous lesions: a possible early biomarker for carcinogenesis. Cancer Res 53: 1783–1787
Wang LD, Zhou Q, Hong JY, Qiu SL and Yang CS (1996) p53 protein accumulation and gene mutations in multifocal esophageal precancerous lesions from symptom free subjects in a high incidence area for esophageal carcinoma in Henan, China. Cancer 77: 1244–1249
Wang LS, Chow KC, Chi KH, Liu CC, Li WY, Chiu JH and Huang MH (1999) Prognosis of esophageal squamous cell carcinoma: analysis of clinicopathological and biological factors. Am J Gastroenterol 94: 1933–1940
Watanabe H, Jass JR and Solin L (1990). Histological typing of oesophageal and gastric tumours 2nd edn. pp 11–18, Springer-Verlag: Berlin, Heidelberg, New York, London, Paris, Tokyo, Hong Kong
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Yasuda, M., Kuwano, H., Watanabe, M. et al. p53 expression in squamous dysplasia associated with carcinoma of the oesophagus: evidence for field carcinogenesis. Br J Cancer 83, 1033–1038 (2000). https://doi.org/10.1054/bjoc.2000.1443
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2000.1443
Keywords
This article is cited by
-
The correlation between the main and minor lesions of synchronous multiple gastric neoplasms assessed gastroscopically and microscopically
Surgical Endoscopy (2024)
-
Incidence of Multiple Metachronous Gastric Cancers After Pyloric‐Preserving Gastrectomy
World Journal of Surgery (2020)
-
Treatment Outcomes of Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy
Scientific Reports (2017)
-
Prognostic significance of p53 expression in patients with esophageal cancer: a meta-analysis
BMC Cancer (2016)
-
Squamous intraepithelial neoplasia of the esophagus: past, present, and future
Journal of Gastroenterology (2009)